Activity Overview
This educational activity is an archive of the live conference held on July 11 – 12, 2026.
Target Audience
This educational activity is directed toward hematologists, medical oncologists, and fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of hematologic malignancies may also participate.
Learning Objectives
- Select appropriate initial therapy using clinical evidence, guidelines, and patient- and disease-specific factors (including biomarkers)
Saad Z. Usmani, MD, MBA, FACP, FASCO
Professor
Chief, Myeloma Service
Memorial Sloan Kettering Cancer Center
New York, NY
Charalampos Charalampous, MD
PGY-4 Hematology-Oncology Fellow
Memorial Sloan Kettering Cancer Center
New York, NY
Jae H. Park, MD
Chief, Cellular Therapy Service
Attending Physician
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, NY
Ran Reshef, MD, MSc
Professor of Medicine at CUMC
Director, Translational Research, Blood and
Marrow Transplantation Program
Director, Cell Therapy Program
Columbia University Irving Medical Center
New York, NY
Shambavi Richard, MD
Associate Professor of Medicine
Director of Myeloma CAR T Research Program
and Stem Cell Transplant
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, NY
Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource®.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
